Scientists have created a blood test that can estimate when Alzheimer’s symptoms are likely to begin. By measuring a protein called p-tau217, the model predicts symptom onset within roughly three to ...
The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...
Morning Overview on MSN
Nitrogen hoarding microbes in Iceland are wrecking the nutrient cycle
In a warming corner of Iceland, tiny soil microbes are quietly rewriting one of Earth’s most fundamental life-support systems ...
Abstract: Microarray data classification is challenged by high dimensionality and small sample sizes, causing feature selection instability. Traditional ensemble feature selection methods struggle to ...
An incorrect Funding statement was provided. The correct Funding statement reads: “The author(s) declare that financial support was received for the research and/or publication of this article. This ...
SAN DIEGO, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced the release of the latest versions of its VIA™ and Solve™ software for genomic data analysis and ...
Objective: Chromosome microarray analysis (CMA) and karyotyping are two important genetic testing techniques used in prenatal diagnosis. This study aims to evaluate the value of chromosome microarray ...
New research from the Data Provenance Initiative has found a dramatic drop in content made available to the collections used to build artificial intelligence. By Kevin Roose Reporting from San ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results